Rui Lan

806 total citations
32 papers, 653 citations indexed

About

Rui Lan is a scholar working on Molecular Biology, Neurology and Complementary and alternative medicine. According to data from OpenAlex, Rui Lan has authored 32 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Neurology and 8 papers in Complementary and alternative medicine. Recurrent topics in Rui Lan's work include Neurological Disease Mechanisms and Treatments (8 papers), Traditional Chinese Medicine Analysis (6 papers) and Animal Virus Infections Studies (4 papers). Rui Lan is often cited by papers focused on Neurological Disease Mechanisms and Treatments (8 papers), Traditional Chinese Medicine Analysis (6 papers) and Animal Virus Infections Studies (4 papers). Rui Lan collaborates with scholars based in China, Sweden and Malawi. Rui Lan's co-authors include Jun Xiang, Dingfang Cai, Guohua Wang, Peiqing Liu, Panxia Wang, Jing Lü, Yong Zhang, Junjian Wang, Zhenzhen Li and Tao Wu and has published in prestigious journals such as Scientific Reports, Journal of Cell Science and International Journal of Molecular Sciences.

In The Last Decade

Rui Lan

28 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Lan China 15 304 168 154 100 94 32 653
Yong Gu China 15 279 0.9× 261 1.6× 97 0.6× 27 0.3× 38 0.4× 28 727
Shanying Huang China 15 300 1.0× 103 0.6× 66 0.4× 29 0.3× 33 0.4× 30 610
Qin Yang China 15 384 1.3× 195 1.2× 91 0.6× 15 0.1× 53 0.6× 35 838
Tianshu Xu China 10 334 1.1× 143 0.9× 120 0.8× 11 0.1× 61 0.6× 37 723
Lina Guan China 16 332 1.1× 55 0.3× 50 0.3× 35 0.3× 36 0.4× 51 614
Hui Du China 10 331 1.1× 80 0.5× 316 2.1× 42 0.4× 14 0.1× 22 809
Ping Zheng China 16 343 1.1× 129 0.8× 91 0.6× 13 0.1× 61 0.6× 50 745
Zhenxing Zhang China 14 275 0.9× 43 0.3× 105 0.7× 44 0.4× 23 0.2× 23 573
Kiyotaka Hoshiai Japan 9 197 0.6× 63 0.4× 50 0.3× 86 0.9× 85 0.9× 24 489

Countries citing papers authored by Rui Lan

Since Specialization
Citations

This map shows the geographic impact of Rui Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Lan more than expected).

Fields of papers citing papers by Rui Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Lan. The network helps show where Rui Lan may publish in the future.

Co-authorship network of co-authors of Rui Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Lan. A scholar is included among the top collaborators of Rui Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Lan. Rui Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoqing, et al.. (2025). Transmembrane mucins in lung adenocarcinoma: understanding of current molecular mechanisms and clinical applications. Cell Death Discovery. 11(1). 163–163. 4 indexed citations
3.
Lan, Rui, Dongrui Ma, Min Zhao, et al.. (2024). Annexin A1: The dawn of ischemic stroke (Review). Molecular Medicine Reports. 31(3).
4.
Li, Yanwei, et al.. (2024). Atherosclerotic renal artery stenosis, mediating biomarkers, and risk of cardiac among individuals with hypertension: A real-world study. IJC Heart & Vasculature. 55. 101556–101556. 2 indexed citations
5.
Lan, Rui, Ran Tao, Tao Li, et al.. (2024). A multimodality score strategy for assessing the risk of immune checkpoint inhibitors related cardiotoxicity. Scientific Reports. 14(1). 24821–24821. 1 indexed citations
6.
Guo, Ruyue, et al.. (2024). Clinical value of thromboelastography in predicting the risk of recurrence of acute ischemic stroke. Frontiers in Neurology. 15. 1420915–1420915.
7.
Gao, Chuanzhou, et al.. (2024). TRP Ion Channels in Immune Cells and Their Implications for Inflammation. International Journal of Molecular Sciences. 25(5). 2719–2719. 9 indexed citations
9.
Shi, Lihong, Qiangsheng Zhang, Qing Tang, et al.. (2023). Pharmacological inhibition of EZH2 using a covalent inhibitor suppresses human ovarian cancer cell migration and invasion. Molecular and Cellular Biochemistry. 479(4). 831–841. 1 indexed citations
10.
Wang, Longlong, et al.. (2021). Circ-SIRT1 inhibits cardiac hypertrophy via activating SIRT1 to promote autophagy. Cell Death and Disease. 12(11). 1069–1069. 42 indexed citations
11.
Li, Zhenzhen, Zhen Guo, Rui Lan, et al.. (2020). The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy. Acta Pharmaceutica Sinica B. 11(5). 1286–1299. 27 indexed citations
12.
Wang, Xiaochun, Xiaoying Yang, Rui Lan, et al.. (2020). Porcine RACK1 negatively regulates the infection of classical swine fever virus and the NF-κB activation in PK-15 cells. Veterinary Microbiology. 246. 108711–108711. 10 indexed citations
13.
Liu, Xiao, Xiangmin Wang, Chao Yang, et al.. (2020). Inhibition of porcine reproductive and respiratory syndrome virus by PKC inhibitor dequalinium chloride in vitro. Veterinary Microbiology. 251. 108913–108913. 7 indexed citations
14.
Wang, Panxia, Zhenzhen Li, Jingyan Li, et al.. (2020). Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin. Pharmacological Research. 161. 105104–105104. 23 indexed citations
15.
Yang, Chao, Rui Lan, Xiaochun Wang, et al.. (2020). Integrin β3, a RACK1 interacting protein, is critical for porcine reproductive and respiratory syndrome virus infection and NF-κB activation in Marc-145 cells. Virus Research. 282. 197956–197956. 14 indexed citations
16.
Wang, Panxia, Rui Lan, Zhen Guo, et al.. (2020). Histone Demethylase JMJD3 Mediated Doxorubicin-Induced Cardiomyopathy by Suppressing SESN2 Expression. Frontiers in Cell and Developmental Biology. 8. 548605–548605. 24 indexed citations
17.
Lan, Rui, et al.. (2018). Mitophagy is activated in brain damage induced by cerebral ischemia and reperfusion via the PINK1/Parkin/p62 signalling pathway. Brain Research Bulletin. 142. 63–77. 81 indexed citations
18.
Zhang, Yong, Rui Lan, Jun Wang, et al.. (2015). Acupuncture reduced apoptosis and up-regulated BDNF and GDNF expression in hippocampus following hypoxia–ischemia in neonatal rats. Journal of Ethnopharmacology. 172. 124–132. 49 indexed citations
19.
Wang, Guohua, et al.. (2014). An-Gong-Niu-Huang Wan protects against cerebral ischemia induced apoptosis in rats: Up-regulation of Bcl-2 and down-regulation of Bax and caspase-3. Journal of Ethnopharmacology. 154(1). 156–162. 57 indexed citations
20.
Lan, Rui, Yong Zhang, Jun Xiang, et al.. (2013). Xiao-Xu-Ming decoction preserves mitochondrial integrity and reduces apoptosis after focal cerebral ischemia and reperfusion via the mitochondrial p53 pathway. Journal of Ethnopharmacology. 151(1). 307–316. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026